OMPI Insider Trading Activity and SEC Form 4 Filings
OMPI insider trading summary
No open-market insider purchases or sales of Obagi Medical Products, Inc. (OMPI) have been reported on SEC Form 4 in the past 12 months.
Latest OMPI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2012 | Preston S Romm | CFO and EVP | Sell | $161K (12,164 @ $13.25) |
| Sep 11, 2012 | Preston S Romm | CFO and EVP | Sell | $842K (63,763 @ $13.20) |
| Sep 11, 2012 | Preston S Romm | CFO and EVP | Sell | $25K (1,900 @ $13.02) |
| Sep 10, 2012 | Preston S Romm | CFO and EVP | Sell | $221K (16,666 @ $13.27) |
| Sep 10, 2012 | Preston S Romm | CFO and EVP | Sell | $13K (978 @ $13.27) |
| Mar 13, 2012 | David S. Goldstein | Executive Vice President | Sell | $208K (16,666 @ $12.51) |
| Dec 9, 2011 | David S. Goldstein | Executive Vice President | Sell | $210K (21,500 @ $9.75) |
| Dec 9, 2011 | David S. Goldstein | Executive Vice President | Sell | $325K (33,334 @ $9.75) |
| Dec 8, 2011 | David S. Goldstein | Executive Vice President | Sell | $10K (1,000 @ $9.84) |
| Nov 18, 2011 | Preston S Romm | CFO and EVP | Sell | $128K (13,179 @ $9.72) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.